Posts in

Archives


Global Counterpoint is by Morgan Stanley MRS Investment Management Division tasked with understanding new or “disruptive” market opportunities that have “the potential to trigger far-reaching consequences” and therefore are likely a solid, long-term investment, and this report focuses on psychedelics for purposes medical. As first shared by Psychedelic Alphathe document provides a concise but solid …